Preparation of substituted quinazolines
Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula 1 are disclosed. Such inhibitors, which include N-[4-(3-chloro-4-floro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, are useful for treating cancer, restenosis, atherosclerosis...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SIMON SCHNEIDER THOMAS ELLIOTT JACKS ROBERT CRAIG HUGHES PETER LAURENCE TOOGOOD KLAUS IRENAUS STEINER ALEXANDER JAMES BRIDGES HUBERT GANGOLF KLEMENS BARTH DENNIS JOSEPH MCNAMARA ROY THOMAS WINTERS RONALD JOSEPH HEEMSTRA NICOLE MARCIA HORNE |
| description | Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula 1 are disclosed. Such inhibitors, which include N-[4-(3-chloro-4-floro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, are useful for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis. The disclosed methods employ protecting schemes to minimize undesirable diacryloylamino-quinazoline side products. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2004209452A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2004209452A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2004209452A13</originalsourceid><addsrcrecordid>eNrjZFAPKEotSCxKLMnMz1PIT1MoLk0qLsksKS1JTVEoLM3MS6zKz8nMSy3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgYmRgaWJqZGjobGxKkCAIuJKXI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Preparation of substituted quinazolines</title><source>esp@cenet</source><creator>SIMON SCHNEIDER ; THOMAS ELLIOTT JACKS ; ROBERT CRAIG HUGHES ; PETER LAURENCE TOOGOOD ; KLAUS IRENAUS STEINER ; ALEXANDER JAMES BRIDGES ; HUBERT GANGOLF KLEMENS BARTH ; DENNIS JOSEPH MCNAMARA ; ROY THOMAS WINTERS ; RONALD JOSEPH HEEMSTRA ; NICOLE MARCIA HORNE</creator><creatorcontrib>SIMON SCHNEIDER ; THOMAS ELLIOTT JACKS ; ROBERT CRAIG HUGHES ; PETER LAURENCE TOOGOOD ; KLAUS IRENAUS STEINER ; ALEXANDER JAMES BRIDGES ; HUBERT GANGOLF KLEMENS BARTH ; DENNIS JOSEPH MCNAMARA ; ROY THOMAS WINTERS ; RONALD JOSEPH HEEMSTRA ; NICOLE MARCIA HORNE</creatorcontrib><description>Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula 1 are disclosed. Such inhibitors, which include N-[4-(3-chloro-4-floro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, are useful for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis. The disclosed methods employ protecting schemes to minimize undesirable diacryloylamino-quinazoline side products.</description><edition>7</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; METALLURGY ; ORGANIC CHEMISTRY</subject><creationdate>2004</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040819&DB=EPODOC&CC=AU&NR=2004209452A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20040819&DB=EPODOC&CC=AU&NR=2004209452A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SIMON SCHNEIDER</creatorcontrib><creatorcontrib>THOMAS ELLIOTT JACKS</creatorcontrib><creatorcontrib>ROBERT CRAIG HUGHES</creatorcontrib><creatorcontrib>PETER LAURENCE TOOGOOD</creatorcontrib><creatorcontrib>KLAUS IRENAUS STEINER</creatorcontrib><creatorcontrib>ALEXANDER JAMES BRIDGES</creatorcontrib><creatorcontrib>HUBERT GANGOLF KLEMENS BARTH</creatorcontrib><creatorcontrib>DENNIS JOSEPH MCNAMARA</creatorcontrib><creatorcontrib>ROY THOMAS WINTERS</creatorcontrib><creatorcontrib>RONALD JOSEPH HEEMSTRA</creatorcontrib><creatorcontrib>NICOLE MARCIA HORNE</creatorcontrib><title>Preparation of substituted quinazolines</title><description>Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula 1 are disclosed. Such inhibitors, which include N-[4-(3-chloro-4-floro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, are useful for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis. The disclosed methods employ protecting schemes to minimize undesirable diacryloylamino-quinazoline side products.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2004</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFAPKEotSCxKLMnMz1PIT1MoLk0qLsksKS1JTVEoLM3MS6zKz8nMSy3mYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxjqFGBgYmRgaWJqZGjobGxKkCAIuJKXI</recordid><startdate>20040819</startdate><enddate>20040819</enddate><creator>SIMON SCHNEIDER</creator><creator>THOMAS ELLIOTT JACKS</creator><creator>ROBERT CRAIG HUGHES</creator><creator>PETER LAURENCE TOOGOOD</creator><creator>KLAUS IRENAUS STEINER</creator><creator>ALEXANDER JAMES BRIDGES</creator><creator>HUBERT GANGOLF KLEMENS BARTH</creator><creator>DENNIS JOSEPH MCNAMARA</creator><creator>ROY THOMAS WINTERS</creator><creator>RONALD JOSEPH HEEMSTRA</creator><creator>NICOLE MARCIA HORNE</creator><scope>EVB</scope></search><sort><creationdate>20040819</creationdate><title>Preparation of substituted quinazolines</title><author>SIMON SCHNEIDER ; THOMAS ELLIOTT JACKS ; ROBERT CRAIG HUGHES ; PETER LAURENCE TOOGOOD ; KLAUS IRENAUS STEINER ; ALEXANDER JAMES BRIDGES ; HUBERT GANGOLF KLEMENS BARTH ; DENNIS JOSEPH MCNAMARA ; ROY THOMAS WINTERS ; RONALD JOSEPH HEEMSTRA ; NICOLE MARCIA HORNE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2004209452A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2004</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><toplevel>online_resources</toplevel><creatorcontrib>SIMON SCHNEIDER</creatorcontrib><creatorcontrib>THOMAS ELLIOTT JACKS</creatorcontrib><creatorcontrib>ROBERT CRAIG HUGHES</creatorcontrib><creatorcontrib>PETER LAURENCE TOOGOOD</creatorcontrib><creatorcontrib>KLAUS IRENAUS STEINER</creatorcontrib><creatorcontrib>ALEXANDER JAMES BRIDGES</creatorcontrib><creatorcontrib>HUBERT GANGOLF KLEMENS BARTH</creatorcontrib><creatorcontrib>DENNIS JOSEPH MCNAMARA</creatorcontrib><creatorcontrib>ROY THOMAS WINTERS</creatorcontrib><creatorcontrib>RONALD JOSEPH HEEMSTRA</creatorcontrib><creatorcontrib>NICOLE MARCIA HORNE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SIMON SCHNEIDER</au><au>THOMAS ELLIOTT JACKS</au><au>ROBERT CRAIG HUGHES</au><au>PETER LAURENCE TOOGOOD</au><au>KLAUS IRENAUS STEINER</au><au>ALEXANDER JAMES BRIDGES</au><au>HUBERT GANGOLF KLEMENS BARTH</au><au>DENNIS JOSEPH MCNAMARA</au><au>ROY THOMAS WINTERS</au><au>RONALD JOSEPH HEEMSTRA</au><au>NICOLE MARCIA HORNE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Preparation of substituted quinazolines</title><date>2004-08-19</date><risdate>2004</risdate><abstract>Methods and materials for preparing irreversible inhibitors of tyrosine kinases of general Formula 1 are disclosed. Such inhibitors, which include N-[4-(3-chloro-4-floro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, are useful for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis. The disclosed methods employ protecting schemes to minimize undesirable diacryloylamino-quinazoline side products.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_AU2004209452A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
| title | Preparation of substituted quinazolines |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T10%3A10%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SIMON%20SCHNEIDER&rft.date=2004-08-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2004209452A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |